Clinical Trial Update: Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals? [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether valacyclovir can delay the need to start antiretroviral therapy in HIV-infected individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Herpes Simplex Virus Type Infection

Drugs mentioned

• VALTREX (valacyclovir hydrochloride)

Snippet

Sponsor: University Health Network, Toronto | Conditions: HIV Infection, Herpes Simplex Type II | Phase 3 | Status: COMPLETED